vs
KADANT INC（KAI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
KADANT INC的季度营收约是REPLIGEN CORP的1.4倍（$271.6M vs $197.9M），KADANT INC净利率更高（10.2% vs 6.7%，领先3.5%），REPLIGEN CORP同比增速更快（13.6% vs -0.0%），KADANT INC自由现金流更多（$44.1M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.7%）
Kadant Inc.创立于1991年，最初是Thermo Electron的子公司，部分股权私有、部分公开交易，2001年完成完全分拆并启用现名。公司服务于造纸、废纸回收、木材加工、物料搬运等多个加工领域，是业务覆盖亚洲、欧洲、北美、南美的跨国企业。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
KAI vs RGEN — 直观对比
营收规模更大
KAI
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出13.7%
-0.0%
净利率更高
KAI
高出3.5%
6.7%
自由现金流更多
KAI
多$26.5M
$17.6M
两年增速更快
RGEN
近两年复合增速
6.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $271.6M | $197.9M |
| 净利润 | $27.7M | $13.3M |
| 毛利率 | 45.2% | 52.5% |
| 营业利润率 | 15.7% | 9.0% |
| 净利率 | 10.2% | 6.7% |
| 营收同比 | -0.0% | 13.6% |
| 净利润同比 | -12.2% | 143.9% |
| 每股收益（稀释后） | $2.35 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KAIRGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | $271.6M | $188.8M | ||
| Q2 25 | $255.3M | $182.4M | ||
| Q1 25 | $239.2M | $169.2M | ||
| Q4 24 | $258.0M | $174.1M | ||
| Q3 24 | $271.6M | $154.9M | ||
| Q2 24 | $274.8M | $154.1M | ||
| Q1 24 | $249.0M | $151.3M |
净利润KAIRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $27.7M | $14.9M | ||
| Q2 25 | $26.2M | $14.9M | ||
| Q1 25 | $24.1M | $5.8M | ||
| Q4 24 | $24.0M | $-30.3M | ||
| Q3 24 | $31.6M | $-654.0K | ||
| Q2 24 | $31.3M | $3.3M | ||
| Q1 24 | $24.7M | $2.1M |
毛利率KAIRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | 45.2% | 53.2% | ||
| Q2 25 | 45.9% | 50.0% | ||
| Q1 25 | 46.1% | 53.6% | ||
| Q4 24 | 43.4% | 26.1% | ||
| Q3 24 | 44.7% | 50.0% | ||
| Q2 24 | 44.4% | 49.8% | ||
| Q1 24 | 44.6% | 49.5% |
营业利润率KAIRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 15.7% | 8.9% | ||
| Q2 25 | 15.4% | 7.6% | ||
| Q1 25 | 14.9% | 3.9% | ||
| Q4 24 | 14.3% | -17.7% | ||
| Q3 24 | 18.0% | -5.1% | ||
| Q2 24 | 17.6% | 1.0% | ||
| Q1 24 | 14.8% | 1.3% |
净利率KAIRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 10.2% | 7.9% | ||
| Q2 25 | 10.2% | 8.2% | ||
| Q1 25 | 10.1% | 3.4% | ||
| Q4 24 | 9.3% | -17.4% | ||
| Q3 24 | 11.6% | -0.4% | ||
| Q2 24 | 11.4% | 2.2% | ||
| Q1 24 | 9.9% | 1.4% |
每股收益（稀释后）KAIRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $2.35 | $0.26 | ||
| Q2 25 | $2.22 | $0.26 | ||
| Q1 25 | $2.04 | $0.10 | ||
| Q4 24 | $2.04 | $-0.55 | ||
| Q3 24 | $2.68 | $-0.01 | ||
| Q2 24 | $2.66 | $0.06 | ||
| Q1 24 | $2.10 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $767.6M |
| 总债务越低越好 | $254.6M | $542.2M |
| 股东权益账面价值 | $949.8M | $2.1B |
| 总资产 | $1.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资KAIRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $124.5M | $748.7M | ||
| Q2 25 | $95.3M | $708.9M | ||
| Q1 25 | $91.7M | $697.2M | ||
| Q4 24 | $94.7M | $757.4M | ||
| Q3 24 | $88.4M | $784.0M | ||
| Q2 24 | $73.8M | $809.1M | ||
| Q1 24 | $81.4M | $780.6M |
总债务KAIRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | $254.6M | $537.9M | ||
| Q2 25 | $245.7M | — | ||
| Q1 25 | $273.5M | — | ||
| Q4 24 | $285.2M | $525.6M | ||
| Q3 24 | $323.2M | — | ||
| Q2 24 | $342.0M | — | ||
| Q1 24 | $306.8M | — |
股东权益KAIRGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | $949.8M | $2.1B | ||
| Q2 25 | $926.0M | $2.1B | ||
| Q1 25 | $876.0M | $2.0B | ||
| Q4 24 | $847.1M | $2.0B | ||
| Q3 24 | $851.7M | $2.0B | ||
| Q2 24 | $807.7M | $2.0B | ||
| Q1 24 | $782.7M | $2.0B |
总资产KAIRGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | $1.5B | $2.9B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.5B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
负债/权益比KAIRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.27× | 0.26× | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.34× | 0.27× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $44.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 16.2% | 8.9% |
| 资本支出强度资本支出/营收 | 1.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.70× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $145.9M | $93.9M |
8季度趋势，按日历期对齐
经营现金流KAIRGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $47.3M | $48.1M | ||
| Q2 25 | $40.5M | $28.6M | ||
| Q1 25 | $22.8M | $15.0M | ||
| Q4 24 | $51.9M | $39.2M | ||
| Q3 24 | $52.5M | $49.3M | ||
| Q2 24 | $28.1M | $42.2M | ||
| Q1 24 | $22.8M | $44.7M |
自由现金流KAIRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $44.1M | $43.4M | ||
| Q2 25 | $36.5M | $21.5M | ||
| Q1 25 | $19.0M | $11.4M | ||
| Q4 24 | $46.3M | $33.6M | ||
| Q3 24 | $48.3M | $42.3M | ||
| Q2 24 | $23.1M | $37.4M | ||
| Q1 24 | $16.6M | $36.4M |
自由现金流率KAIRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 16.2% | 23.0% | ||
| Q2 25 | 14.3% | 11.8% | ||
| Q1 25 | 7.9% | 6.8% | ||
| Q4 24 | 17.9% | 19.3% | ||
| Q3 24 | 17.8% | 27.3% | ||
| Q2 24 | 8.4% | 24.3% | ||
| Q1 24 | 6.7% | 24.0% |
资本支出强度KAIRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 1.6% | 3.9% | ||
| Q1 25 | 1.6% | 2.1% | ||
| Q4 24 | 2.2% | 3.2% | ||
| Q3 24 | 1.5% | 4.5% | ||
| Q2 24 | 1.8% | 3.1% | ||
| Q1 24 | 2.5% | 5.5% |
现金转化率KAIRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.70× | 3.23× | ||
| Q2 25 | 1.55× | 1.92× | ||
| Q1 25 | 0.95× | 2.57× | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 0.90× | 12.70× | ||
| Q1 24 | 0.92× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KAI
| Flow Control | $94.8M | 35% |
| Capital | $83.2M | 31% |
| Material Handling Systems | $70.3M | 26% |
| Transferred Over Time | $17.1M | 6% |
| Other | $6.1M | 2% |
RGEN
暂无分部数据
